×
S&P 500   3,911.74 (+3.06%)
DOW   31,500.68 (+2.68%)
QQQ   294.61 (+3.43%)
AAPL   141.66 (+2.45%)
MSFT   267.70 (+3.41%)
META   170.16 (+7.19%)
GOOGL   2,359.50 (+5.11%)
AMZN   116.46 (+3.58%)
TSLA   737.12 (+4.52%)
NVDA   171.26 (+5.55%)
NIO   24.08 (+4.47%)
BABA   117.62 (+4.91%)
AMD   87.08 (+5.64%)
MU   58.44 (+3.95%)
CGC   3.77 (+4.72%)
T   20.99 (+1.84%)
GE   67.08 (+4.70%)
F   12.01 (+3.89%)
DIS   97.78 (+3.69%)
AMC   12.47 (+3.49%)
PFE   51.59 (+2.99%)
PYPL   77.68 (+5.24%)
NFLX   190.85 (+5.03%)
S&P 500   3,911.74 (+3.06%)
DOW   31,500.68 (+2.68%)
QQQ   294.61 (+3.43%)
AAPL   141.66 (+2.45%)
MSFT   267.70 (+3.41%)
META   170.16 (+7.19%)
GOOGL   2,359.50 (+5.11%)
AMZN   116.46 (+3.58%)
TSLA   737.12 (+4.52%)
NVDA   171.26 (+5.55%)
NIO   24.08 (+4.47%)
BABA   117.62 (+4.91%)
AMD   87.08 (+5.64%)
MU   58.44 (+3.95%)
CGC   3.77 (+4.72%)
T   20.99 (+1.84%)
GE   67.08 (+4.70%)
F   12.01 (+3.89%)
DIS   97.78 (+3.69%)
AMC   12.47 (+3.49%)
PFE   51.59 (+2.99%)
PYPL   77.68 (+5.24%)
NFLX   190.85 (+5.03%)
S&P 500   3,911.74 (+3.06%)
DOW   31,500.68 (+2.68%)
QQQ   294.61 (+3.43%)
AAPL   141.66 (+2.45%)
MSFT   267.70 (+3.41%)
META   170.16 (+7.19%)
GOOGL   2,359.50 (+5.11%)
AMZN   116.46 (+3.58%)
TSLA   737.12 (+4.52%)
NVDA   171.26 (+5.55%)
NIO   24.08 (+4.47%)
BABA   117.62 (+4.91%)
AMD   87.08 (+5.64%)
MU   58.44 (+3.95%)
CGC   3.77 (+4.72%)
T   20.99 (+1.84%)
GE   67.08 (+4.70%)
F   12.01 (+3.89%)
DIS   97.78 (+3.69%)
AMC   12.47 (+3.49%)
PFE   51.59 (+2.99%)
PYPL   77.68 (+5.24%)
NFLX   190.85 (+5.03%)
S&P 500   3,911.74 (+3.06%)
DOW   31,500.68 (+2.68%)
QQQ   294.61 (+3.43%)
AAPL   141.66 (+2.45%)
MSFT   267.70 (+3.41%)
META   170.16 (+7.19%)
GOOGL   2,359.50 (+5.11%)
AMZN   116.46 (+3.58%)
TSLA   737.12 (+4.52%)
NVDA   171.26 (+5.55%)
NIO   24.08 (+4.47%)
BABA   117.62 (+4.91%)
AMD   87.08 (+5.64%)
MU   58.44 (+3.95%)
CGC   3.77 (+4.72%)
T   20.99 (+1.84%)
GE   67.08 (+4.70%)
F   12.01 (+3.89%)
DIS   97.78 (+3.69%)
AMC   12.47 (+3.49%)
PFE   51.59 (+2.99%)
PYPL   77.68 (+5.24%)
NFLX   190.85 (+5.03%)
OTCMKTS:OPTHF

Optimi Health News Headlines

$0.24
+0.01 (+5.07%)
(As of 06/24/2022 02:23 PM ET)
Add
Compare
Today's Range
$0.22
$0.24
50-Day Range
$0.15
$0.35
52-Week Range
$0.13
$1.22
Volume
2,600 shs
Average Volume
27,397 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get Optimi Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPTHF and its competitors with MarketBeat's FREE daily newsletter.

OPTHF Media Mentions By Week

OPTHF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OPTHF
News Sentiment

1.42

0.11

Average
Process Industries
News Sentiment

OPTHF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OPTHF Articles
This Week

1

1

OPTHF Articles
Average Week



OPTHF Stock News Headlines Today

SourceHeadline
finance.yahoo.com logoOptimi Health Requests Approval To Manufacture MDMA, Other Synthetic Psychedelics
finance.yahoo.com - June 20 at 6:52 PM
MarketBeat logoOptimi Health Corp. (OTCMKTS:OPTHF) Short Interest Update
americanbankingnews.com - June 12 at 5:14 AM
finance.yahoo.com logoOptimi Health Finalizes Partnership and Psilocybin Supply Agreement With ATMA Journey Centers
finance.yahoo.com - June 8 at 9:25 AM
seekingalpha.com logoOptimi Health inks contract to supply psilocybin mushrooms to Filament Health
seekingalpha.com - May 31 at 12:20 PM
finance.yahoo.com logoOptimi Health Enters Into Psilocybin Supply Agreement With Filament Health
finance.yahoo.com - May 31 at 12:20 PM
proactiveinvestors.com logoCreso Pharma’s psychedelics company signs psilocybin supply agreement
proactiveinvestors.com - May 29 at 10:46 PM
finance.yahoo.com logoOpen For Business: Optimi Completes First Grow of Psilocybin Mushrooms and Introduces Head of Cultivation
finance.yahoo.com - May 25 at 6:19 PM
benzinga.com logoOptimi Completes First Grow of Psilocybin Mushrooms, Introduces New Head Of Cultivation
benzinga.com - May 25 at 2:00 PM
finance.yahoo.com logoU.K. Member of Parliament Crispin Blunt To Inaugurate Psilocybin Cultivation Facility At Optimi Health Grand Opening
finance.yahoo.com - May 19 at 9:16 AM
msn.com logoOptimi Health Adds Large Portfolio Of Magic Mushrooms Strains To Its Genetic Bank
msn.com - May 18 at 1:14 PM
finance.yahoo.com logoOptimi Health Acquires Extensive Catalog of Psychedelic and Functional Mushroom Genetics
finance.yahoo.com - May 17 at 3:59 PM
finance.yahoo.com logoOptimi Health Completes Expansion Of On-Site Analytical Laboratory
finance.yahoo.com - May 11 at 2:04 PM
finance.yahoo.com logoOptimi Health Applauds Health Canada’s Position on Drug Quality and Goods and Manufacturing Practices (GMP) for Psilocybin
finance.yahoo.com - May 9 at 12:42 PM
finance.yahoo.com logoOptimi Health Granted Amendment To Controlled Substances Dealer’s Licence
finance.yahoo.com - May 4 at 12:08 PM
finance.yahoo.com logoOptimi Health Opens Canada’s Largest GMP-Grade Licensed Psilocybin Cultivation Facility
finance.yahoo.com - April 28 at 3:34 PM
finance.yahoo.com logoOptimi Health Begins Cultivation Of Natural Psilocybin For Use In Clinical Trials
finance.yahoo.com - March 18 at 11:33 AM
finance.yahoo.com logoOptimi Health Announces Investor Relations Agreement
finance.yahoo.com - March 8 at 6:13 PM
finance.yahoo.com logoOptimi Health Upgrades Trading to the OTCQX Best Market
finance.yahoo.com - March 1 at 7:36 PM
finance.yahoo.com logoOptimi Health Launches E-Commerce Platform Featuring All-Natural Functional Mushroom Supplements
finance.yahoo.com - February 22 at 4:56 PM
finance.yahoo.com logoUPDATE - Optimi Health Launches E-Commerce Platform Featuring All-Natural Functional Mushroom Supplements
finance.yahoo.com - February 22 at 4:56 PM
baystreet.ca logoSubsidiary Announcement Sent Parent Co. Shares Flying
baystreet.ca - February 17 at 2:02 AM
finance.yahoo.com logoOptimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program
finance.yahoo.com - February 16 at 11:57 AM
finance.yahoo.com logoOptimi Health Dealer’s License Granted by Health Canada
finance.yahoo.com - February 7 at 10:42 AM
finance.yahoo.com logoOptimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent
finance.yahoo.com - January 18 at 9:27 AM
finance.yahoo.com logoOptimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent
finance.yahoo.com - January 18 at 9:27 AM
benzinga.com logoOptimi Health Provides Dealer License Update and Comments on Health Canada's Amendments to the Special Access Program (SAP)
benzinga.com - January 7 at 9:25 AM
finance.yahoo.com logoOptimi Health Provides Dealer License Update and Comments on Health Canada’s Amendments to the Special Access Program (SAP)
finance.yahoo.com - January 5 at 5:50 PM
finance.yahoo.com logoOptimi Health Requests Final Inspection for Dealer’s License
finance.yahoo.com - December 7 at 1:20 PM
finance.yahoo.com logoOptimi Health Appoints Principal Investigator for Clinical Dosing Study
finance.yahoo.com - December 7 at 8:19 AM
finance.yahoo.com logoOptimi Health Engages Expert Management Consultancy to Drive Corporate Visibility
finance.yahoo.com - December 7 at 8:19 AM
Get Optimi Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPTHF and its competitors with MarketBeat's FREE daily newsletter.

This page (OTCMKTS:OPTHF) was last updated on 6/24/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.